Latest Decisions in Takeover Matters

08.03.2022

Decision 810/01 dated 8 March 2022 in the matter of Santhera Pharmaceuticals Holding AG

In its decision 810/01 dated 8 March 2022 in the matter of Santhera Pharmaceuticals Holding AG, the Swiss Takeover Board has granted Santhera Pharmaceuticals (Schweiz) AG an exemption from the duty to make a public tender offer concerning Santhera Pharmaceuticals Holding AG.

Click here to view the decision 810/01.

24.02.2022

Decision 805/02 dated 24 February 2022 in the matter of Bank Linth LLB AG

In its decision 805/02 dated 24 February 2022 in the matter of Bank Linth LLB AG, the Swiss Takeover Board has ascertained the compliance of the purchase and partial exchange offer of Liechtensteinische Landesbank AG to the shareholders of Bank Linth LLB AG with the legal requirements and has made additional statements with respect to this offer.

Click here to view the decision 805/02.

11.02.2022

Decision 806/01 dated 11 February 2022 in the matter of AP Alternative Portfolio AG

In its decision 806/01 dated 11 February 2022 in the matter of AP Alternative Portfolio AG, the Swiss Takeover Board has exempted the public buyback program of AP Alternative Portfolio Ltd. from the provisions governing public takeovers offers.

Click here to view the decision 806/01.

26.01.2022

Decision 805/01 dated 26 January 2022 in the matter of Bank Linth LLB AG

In its decision 805/01 dated 26 January 2022 in the matter of Bank Linth LLb AG, the Swiss Takeover Board has made statements regarding the purchase and partial exchange offer of Liechtensteinische Landesbank AG to the shareholders of Bank Linth LLB AG.

Click here to view the decision 805/01.

24.01.2022

Decision 804/01 dated 24 January 2022 in the matter of Spice Private Equity AG

In its decision 804/01 dated 24 January 2022 in the matter of Spice Private Equity AG, the Swiss Takeover Board has made statements regarding the buyback program of Spice Private Equity Ltd.

Click here to view the decision 804/01.

14.01.2022

Decision 802/02 dated 14 January 2022 in the matter of Vifor Pharma AG

In its decision 802/02 dated 14 January 2022 in the matter of Vifor Pharma AG, the Swiss Takeover Board has ascertained the compliance of the public tender offer of CSL Berhing AG to the shareholders of Vifor Pharma AG with the legal requirements and made some statements regarding the handling of the employee participation programs of Vifor Pharma AG in respect of the public offer of CSL Berhing AG to the shareholders of Vifor Pharma AG.

Click here to view the decision 802/02.

* Decision not yet included in the Case Law Commentary on takeoverpractice.ch.